All news updating

News

Choose a section

Loading sections…

News (EN)
Beyond GMOs: How CRISPR Is Changing Crop Production, Feed Manufacturing and Agricultural Biotechnology
23.10.2026
CRISPR is reshaping crop breeding and feed production, opening new opportunities in agricultural biotechnology.
Can we develop crops that are more drought-tolerant, less susceptible to disease and nutritionally improved? Genome editing is already helping scientists address these challenges. Now, new EU rules could accelerate the adoption of promising innovations in agriculture.

CRISPR: How Can Scientists Improve Plants?

Imagine a plant’s DNA as an instruction manual that determines what the plant will be like: how well it withstands drought, how effectively it resists disease and what nutritional properties its harvest will have.

CRISPR is a kind of genetic editor that allows scientists to identify specific sections of this manual and make targeted changes. For example, they can modify the activity of a gene that makes a plant vulnerable to a particular disease or influence the composition of substances within the plant.

Unlike conventional breeding, which often involves crossing plants over many years and selecting those with desirable traits, CRISPR allows scientists to target specific sections of DNA directly. This can speed up the development of new varieties with useful characteristics.

For agriculture, this creates opportunities to develop crops that withstand drought better, suffer less from disease or have nutritional profiles better suited to particular production needs.

Precision is a key advantage. Scientists can target specific genes without necessarily introducing genetic material from another organism. This is why some plants developed using CRISPR may be regulated differently from conventional genetically modified organisms (GMOs).
Oakmont Solutions Expert Commentary:

The CRISPR/Cas9 gene-editing system is a novel, simple and effective genetic engineering tool for the 21st century. The CRISPR/Cas9 gene-editing system does not itself introduce any transgenes; it modifies the genome solely by locally switching off a target gene. This can, for example, eliminate a harmful genetic mutation from the genome (that is, the complete set of genes in a living organism). The CRISPR/Cas9 tool always works quickly, accurately and reliably.

Anton Anatolyevich Volotovich, Head of Innovative Biotechnology, Candidate of Biological Sciences, Associate Professor
New EU Rules for Genome Editing

On 17 June 2026, the European Parliament and the Council of the EU adopted Regulation (EU) 2026/1388, which governs plants developed using certain new genomic techniques (NGTs), as well as food and feed derived from them.

The regulation entered into force on 16 July 2026, but its main provisions will not apply until 17 July 2028.

Under the new rules, these plants will be divided into two groups. The first group (NGT-1) covers plants with genetic changes comparable to those that could be achieved through conventional breeding. These plants will be subject to simplified requirements. The second group (NGT-2) will remain subject to the main rules applicable to GMOs, including safety assessments and labelling requirements.

The new rules will begin to apply on 17 July 2028. This approach will allow plants to be assessed according to the nature of the genetic changes they contain, rather than applying identical requirements to all technologies.

What does this mean for the industry? For plant breeders and biotechnology companies, the path from laboratory research to market could become simpler and faster. This creates additional opportunities to bring agricultural innovations into practical use.

CRISPR in Action: Examples from Around the World

Japan: Tomatoes with enhanced properties. In 2021, Sicilian Rouge High GABA tomatoes developed through genome editing entered the Japanese market. They contain elevated levels of GABA (gamma-aminobutyric acid). This example shows how targeted genetic changes can be used to develop products with specific characteristics.

India: Rice for challenging growing conditions. Indian researchers are developing genome-edited rice varieties designed to improve yields, shorten maturation times and increase resilience to climate-related stresses. These advances are particularly important in regions where drought and other adverse conditions threaten food security.

China: Soybeans with an improved oil profile. Researchers are using CRISPR to modify the fatty acid composition of soybeans, including efforts to increase the proportion of oleic acid. This is a promising area for the food industry and oilseed processing, although individual research results do not yet mean that these varieties have been adopted commercially on a widespread scale.

What Could This Mean for Agriculture and Livestock Production?

The potential benefits extend far beyond the laboratory:

  • Crop production: Greater resistance to disease and drought could reduce crop losses and potentially lower the need for certain plant protection products.
  • Feed production: The ability to obtain raw materials with improved protein and oil profiles could help meet nutritional requirements and improve supply stability in the face of climate risks.
  • Livestock production: More predictable feed ingredient characteristics could help producers manage feed quality, formulate rations and control production costs.

However, the new rules do not automatically authorise all genome-edited crops for sale in the EU. The actual impact will depend on the characteristics of individual varieties, testing results and the requirements governing their intended use.

From Genetic Changes to Practical Solutions

CRISPR will not solve every challenge facing agriculture, but it is expanding the options available to plant breeders and biotechnology developers. Experience from different countries shows that genome editing can benefit both agricultural producers and the processing industries that depend on crop quality and composition.

For agribusinesses, changes to EU legislation are a reason to assess emerging technologies early, considering their economic potential and suitability for specific production needs. The better companies understand the capabilities and limitations of CRISPR today, the more confidently they will be able to adapt to tomorrow’s market.